Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-marketing Surveillance Study of the Effectiveness and Safety of New Oral Antivirals for Outpatients With Mild-moderate COVID-19

NCT05894603 is registered in ClinicalTrials.gov with Universidade do Porto as lead sponsor.

NCT NCT05894603
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05894603 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-marketing Surveillance Study of the Effectiveness and Safety of New Oral Antivirals for Outpatients With Mild-moderate COVID-19
Lead sponsor
Universidade do Porto
Phase
Observational
Overall status
Unknown status
Start date
August 1, 2022
Completion date
June 30, 2024
Enrollment
211 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19